Skip to main content
Signal8

Langsam Jeffrey

SEC insider (Form 3/4/5 filer). CIK 0002069752. Chief Clinical Officer at Oncology Institute, Inc. (TOI). 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 27, 2026. Located in CERRITOS, CA.

Companies Langsam Jeffrey has filed insider reports for

  • Oncology Institute, Inc. (TOI): Officer, Chief Clinical Officer
Langsam Jeffrey profile photo

Langsam Jeffrey

CIK: 0002069752

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Oncology Institute, Inc. logo
TOI

Oncology Institute, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Oncology Institute, Inc. logo
    TOI

    Oncology Institute, Inc.

    Mar 27, 2026
    Award
    Direct
    70.3K shares-
  • Oncology Institute, Inc. logo
    TOI

    Oncology Institute, Inc.

    May 21, 2025
    Award
    Direct
    57.4K shares-

1-2 of 2